LSE - Delayed Quote GBp

Futura Medical plc (FUM.L)

Compare
32.95 -0.22 (-0.68%)
At close: November 22 at 4:45 PM GMT
Loading Chart for FUM.L
DELL
  • Previous Close 33.17
  • Open 32.50
  • Bid 32.55 x --
  • Ask 33.50 x --
  • Day's Range 32.50 - 33.95
  • 52 Week Range 23.28 - 47.80
  • Volume 481,049
  • Avg. Volume 653,488
  • Market Cap (intraday) 100.754M
  • Beta (5Y Monthly) 1.26
  • PE Ratio (TTM) --
  • EPS (TTM) -0.01
  • Earnings Date Sep 10, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.34

Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

www.futuramedical.com

12

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FUM.L

View More

Performance Overview: FUM.L

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

FUM.L
29.22%
FTSE 100
6.84%

1-Year Return

FUM.L
10.76%
FTSE 100
10.43%

3-Year Return

FUM.L
4.22%
FTSE 100
14.38%

5-Year Return

FUM.L
3.78%
FTSE 100
14.14%

Compare To: FUM.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FUM.L

View More

Valuation Measures

Annual
As of 11/22/2024
  • Market Cap

    100.07M

  • Enterprise Value

    96.15M

  • Trailing P/E

    --

  • Forward P/E

    11.44

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    12.13

  • Price/Book (mrq)

    12.82

  • Enterprise Value/Revenue

    11.45

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -44.68%

  • Return on Assets (ttm)

    -26.59%

  • Return on Equity (ttm)

    -47.43%

  • Revenue (ttm)

    8.4M

  • Net Income Avi to Common (ttm)

    -3.75M

  • Diluted EPS (ttm)

    -0.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.92M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -3M

Research Analysis: FUM.L

View More

Company Insights: FUM.L

Research Reports: FUM.L

View More

People Also Watch